-
Artificial intelligence chatbot interpretation of ophthalmic multimodal imaging cases Eye (IF 3.9) Pub Date : 2024-04-22 Andrew Mihalache, Ryan S. Huang, Miguel Cruz-Pimentel, Nikhil S. Patil, Marko M. Popovic, Bhadra U. Pandya, Reut Shor, Austin Pereira, Rajeev H. Muni
The integration of artificial intelligence (AI) within ophthalmology represents a paradigm shift that can redefine patient interactions and healthcare delivery [1]. The large language model ChatGPT-4 (OpenAI) has been recognized for its rapidly advancing proficiency in medical prompt analysis [2, 3]. While earlier iterations of this chatbot were confined to text-based input, our recent work has documented
-
Hydrogen inhalation therapy for inflammation and eye diseases: a review of the literature Eye (IF 3.9) Pub Date : 2024-04-18 Yoshiyasu Takefuji
An exhaustive survey of existing literature was conducted to investigate the relationship between hydrogen inhalation therapy, inflammation, and ocular disordhers. The burgeoning body of evidence indicates that hydrogen inhalation therapy might be a promising approach to alleviate not only inflammation but also related eye diseases. Liang et al. investigated the effect of hydrogen gas inhalation on
-
Severe ocular chemical injury in the UK: a British Ophthalmological Surveillance Unit study Eye (IF 3.9) Pub Date : 2024-04-18 Nicola Cronbach, Barny Foot, Richard Scawn
-
Comparing the morphology of optic nerve head and lamina cribrosa in full-term and preterm school-aged children Eye (IF 3.9) Pub Date : 2024-04-17 Yung-Sung Lee, Eugene Yu-Chuan Kang, Henry Shen-Lih Chen, Po‑Han Yeh, Wei-Chi Wu
-
Choroidal neovascularization following self-inflicted laser pointer injury to the macula Eye (IF 3.9) Pub Date : 2024-04-16 Peter Kiraly, Chandan Amit Patel
-
How do I recognise and manage visual snow syndrome? Eye (IF 3.9) Pub Date : 2024-04-16 Clare L. Fraser
Visual snow syndrome (VSS) is becoming increasingly recognised by clinicians and self-diagnosed by our patients thanks to online search tools. Previously this phenomenon was overlooked or dismissed leading to increased patient anxiety. Now, however, we need to be careful with that we are not making what would seem to be an easy diagnosis of VSS when actually we are missing any underlying or mimic conditions
-
Corneal neuropathic pain: a review to inform clinical practice Eye (IF 3.9) Pub Date : 2024-04-16 Stephanie L. Watson, Damien Tuan-Man Le
-
Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice Eye (IF 3.9) Pub Date : 2024-04-16 Francesco Testa, Giacomo Bacci, Benedetto Falsini, Giancarlo Iarossi, Paolo Melillo, Dario Pasquale Mucciolo, Vittoria Murro, Anna Paola Salvetti, Andrea Sodi, Giovanni Staurenghi, Francesca Simonelli
-
Enhancing Ophthalmic Triage: identification of new clinical features to support healthcare professionals in triage Eye (IF 3.9) Pub Date : 2024-04-16 Anish Jindal, Camilo Brandao-de-Resende, Yan Ning Neo, Mariane Melo, Alexander C. Day
Objective To investigate which features from a patient’s history are either high or low risk that could support healthcare professionals in ophthalmic emergency triage. Methods Prospective, 12,584 visits from 11,733 adult patients attending an Accident and Emergency department at a single tertiary centre were analysed. Data were collected by ophthalmic nurses working in triage, using an online form
-
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy Eye (IF 3.9) Pub Date : 2024-04-15 Yasir Jamal Sepah, Diana V. Do, Marina Mesquida, Bann-Mo Day, Steven Blotner, Rubbia Afridi, Muhammad Sohail Halim, Kyu Hong, Eric Wakshull, Sascha Fauser, Ivaylo Stoilov, Quan Dong Nguyen
-
Quantitative evaluation of OCT angiography images in healthy and glaucomatous subjects through a novel approach: exploring inter-image variability Eye (IF 3.9) Pub Date : 2024-04-13 Paola Cassottana, Costanza Iester, Laura Bonzano, Carlo E. Traverso, Michele Iester
-
Google Gemini and Bard artificial intelligence chatbot performance in ophthalmology knowledge assessment Eye (IF 3.9) Pub Date : 2024-04-13 Andrew Mihalache, Justin Grad, Nikhil S. Patil, Ryan S. Huang, Marko M. Popovic, Ashwin Mallipatna, Peter J. Kertes, Rajeev H. Muni
-
Long-term results of accelerated corneal collagen crosslinking in paediatric patients with progressive keratoconus: 10-year follow-up Eye (IF 3.9) Pub Date : 2024-04-12 Sibel Ahmet, Gizem Yayla Akincilar, Ahmet Kirgiz, Nilay Kandemir Besek, Burcu Kemer Atik, Husna Topcu, Gunes Gumus Kasapoglu
-
The potential effects of newer groups of glucose lowering drugs on age-related macular degeneration Eye (IF 3.9) Pub Date : 2024-04-11 Moein Ebrahimi, Sobha Sivaprasad
Age-related macular degeneration (AMD) is a multifactorial disease. The prevalence of AMD is expected to rise to 288 million worldwide by 2040 [1]. The pathophysiology of AMD is complex, and the treatment paradigm is suboptimal. Intravitreal anti-vascular growth factor (anti-VEGF) agents such as ranibizumab, bevacizumab, and aflibercept are the most commonly used therapies for exudative neovascular
-
Factors influencing treatment and time spent with physicians in patients with uveitis compared to other ophthalmology subspecialties in the National Ambulatory Medical Care Survey Eye (IF 3.9) Pub Date : 2024-04-11 Rayna F. Marshall, Meghan Berkenstock
-
‘Off the shelf’ toric intraocular lenses to allow better access in public healthcare: a randomised control study Eye (IF 3.9) Pub Date : 2024-04-10 Khayam Naderi, Ashmal Jameel, Sancy Low, Vijay Wagh, Mani Bhogal, Ailsa Ritchie, Scott Robbie, Chris Hammond, Moin Mohamed, Nick Stanojcic, Elodie Azan, Lily Lai, Chris Hull, David O’Brart
Despite published benefits [1], toric intraocular lenses (TIOLs) comprise only 0.4% of IOLs implanted in the NHS [2]. Reasons include typically higher IOL prices, delivery logistics/costs as on-site storage of TIOLs is impractical due to large numbers of TIOL spherical and cylindrical combinations, and increased consultation/operative and administration times [3]. By using TIOLs with only two-cylinder
-
Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies Eye (IF 3.9) Pub Date : 2024-04-10 Pushpinder Kanda, Arnav Gupta, Jobanpreet Dhillon, Deeksha Kundapur, Chloe C. Gottlieb
-
Prevalence of presenting bilateral visual impairment associated with refractive error – findings from the See4School, pre-school vision screening programme in NHS Scotland Eye (IF 3.9) Pub Date : 2024-04-10 Lee Pentland, Miriam Louise Conway
-
Changes in foveal avascular zone parameters in individuals with prediabetes compared to normoglycemic controls: a systematic review and meta-analysis Eye (IF 3.9) Pub Date : 2024-04-08 Dimitrios Kazantzis, Christopher Holmes, Naomi Wijesingha, Sobha Sivaprasad
-
The value of virtual glaucoma clinics: a review Eye (IF 3.9) Pub Date : 2024-04-08 Rachel Mercer, Pouya Alaghband
Virtual clinics are being utilised to tackle the growing demand for glaucoma healthcare. We conducted a literature search on 28 February 2023 using MEDLINE (PubMed), EMBASE and Web of Science databases. We searched for studies on virtual glaucoma clinics, published in the English language between 2000 and 2023. Studies suggest that virtual glaucoma clinics are a safe and effective alternative to traditional
-
Comment on: Surgical technique, perioperative management and early outcome data of the PAUL glaucoma drainage device, dated September 2021 Eye (IF 3.9) Pub Date : 2024-04-08 Michelle Dinsdale, Leon Au
Vallabh et al. [1] from Manchester Royal Eye Hospital, described the surgical technique for the PAUL glaucoma drainage device, including using a 6/0 prolene suture as an intraluminal stent to prevent early post-operative hypotony, which we believe has been widely adopted. This correspondence offers an update regarding this surgical technique. The authors of this original article have noticed cases
-
Comment on: “Lesion area progression in eyes with neovascular age-related macular degeneration treated using a proactive or a reactive regimen” Eye (IF 3.9) Pub Date : 2024-04-08 Andrés Felipe Niño-Joya, Alexander M. Martínez-Blanco, Omar Salamanca, Francisco J. Bonilla-Escobar
We commend the study conducted by Cozzi et al. [1] for its insightful contributions to the ongoing management of patients with neovascular age-related macular degeneration (nAMD) undergoing an anti-VEGF intravitreal regimen. This retrospective cohort study, carried out in centers across Italy and Australia, meticulously examined the progression of neovascular lesion areas, identifying differences between
-
Evolving generation of new Extended Depth of Focus intraocular lenses Eye (IF 3.9) Pub Date : 2024-04-05 Mayank A. Nanavaty
-
Deprivation and follow-up issues following “perfect” pterygium surgery in the NHS Eye (IF 3.9) Pub Date : 2024-04-05 Megan Quinn, Toby Boote, David Lockington
Pterygia are degenerative fibrovascular conjunctival growths; they can be asymptomatic or affect vision by inducing corneal astigmatism or visual axis involvement. In 2008, Hirst reported results of the ‘Pterygium Extended Removal followed by Extended Conjunctival Transplantation (PERFECT)’ technique with extremely low recurrence rates (0.05% at 1 year) [1]. Despite this template, there is no agreed
-
Quality of vision clinical outcomes for a new fully-refractive extended depth of focus Intraocular Lens Eye (IF 3.9) Pub Date : 2024-04-05 Dean Corbett, Daniel Black, Timothy V. Roberts, Brendan Cronin, David Gunn, Chandra Bala, Patrick Versace, Linda Tsai, Eleni Papadatou, Aixa Alarcon, Srividhya Vilupuru
Background/objective To evaluate the visual performance of a purely refractive extended depth of focus (EDF) intraocular lens (IOL). Subjects/methods A prospective, multi-center, randomized, subject/evaluator-masked study. Subjects were bilaterally implanted with the EDF test (Model ZEN00V, N = 60) or an enhanced monofocal control (Model ICB00, N = 57) IOL. Monocular corrected distance (CDVA), intermediate
-
Tolerance to refractive error with a new extended depth of focus intraocular lens Eye (IF 3.9) Pub Date : 2024-04-05 Daniel A. Black, Chandra Bala, Aixa Alarcon, Srividhya Vilupuru
Purpose To evaluate the tolerance to refractive errors of a new purely refractive extended depth of focus (EDF) intraocular lens (IOL) using preclinical and clinical metrics. Methods Preclinical evaluation included computer simulations of visual acuity (sVA) and dysphotopsia profile of different IOL designs (refractive EDF, diffractive EDF, multifocal, standard, and enhanced monofocals) using an appropriate
-
Optical and clinical simulated performance of a new refractive extended depth of focus intraocular lens Eye (IF 3.9) Pub Date : 2024-04-05 Aixa Alarcon, Antonio del Aguila Carrasco, Franck Gounou, Henk Weeber, Carmen Cánovas, Patricia Piers
Objectives The purpose of this study is to evaluate the optical and expected clinical performance of a new refractive Extended Depth of Focus (EDF) intraocular lens (IOL) designed to maintain a monofocal-like dysphotopsia profile. Methods Simulated visual acuity (sVA) with varying defocus was calculated using the area under the Modulation Transfer Function measured in an average eye model and from
-
Simulation-based training for intraoperative posterior capsule rupture management: an analysis of nontechnical skills development and the relationship between technical and nontechnical skills Eye (IF 3.9) Pub Date : 2024-04-04 Thomas Charles Wood, Sundas Maqsood, Alexander Saunders, William Sancha, Mayank A. Nanavaty, Michael Wearne, Saul Rajak
Objectives To analyse development of individual nontechnical skills (NTS) domains after undertaking a previously developed simulation-based training model and analyse the relationship between technical skills (TS) and NTS in ophthalmic surgery. Methods The simulation-based training model involved a cataract surgery case complicated by intraoperative posterior capsule rupture. Cataract surgeons underwent
-
Priorities in school eye health in low and middle-income countries a scoping review Eye (IF 3.9) Pub Date : 2024-04-02 Alex-Anne Harvey, Priya Morjaria, Benoit Tousignant
School eye health (SEH) has been on the global agenda for many years, and there is mounting evidence available to support that school-based visual screenings are one of the most effective and cost-efficient interventions to reach children over five years old. A scoping review was conducted in MEDLINE, Web of Science, PubMed, and CINHAL between February and June 2023 to identify current priorities in
-
Comparing efficacy of charged-particle therapy with brachytherapy in treatment of uveal melanoma Eye (IF 3.9) Pub Date : 2024-04-02 Yu-Hsuan Tseng, Chia-An Hsu, Yu-Bai Chou
Background Uveal melanoma (UM) is the most common primary ocular tumour in adults. The most used eye-preserving treatments are charged-particle therapy (CPT) and brachytherapy. We performed a systematic review and meta-analysis to compare efficacies and complications of these two radiotherapies. Methods We searched EMBASE, PubMed, MEDLINE, and the Cochrane Library from January 2012 to December 2022
-
Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020 Eye (IF 3.9) Pub Date : 2024-04-02
Objectives To estimate global and regional trends from 2000 to 2020 of the number of persons visually impaired by glaucoma and their proportion of the total number of vision-impaired individuals. Methods A systematic review and meta-analysis of published population studies and grey literature from 2000 to 2020 was carried out to estimate global and regional trends in number of people with vision loss
-
Tessellated fundus occurs earlier than myopia in children aged 3–6 years Eye (IF 3.9) Pub Date : 2024-03-30 Xuejing Mi, Yuxin Fang, Jianing Pu, Wei Chen, Zhen Zhou, Mengmeng Qin, Ranran Zhang, Dan Wang, Yanyan Yang, Chuzhi Peng, Shimeng Bian, Huaying Xu, Yonghong Jiao
Background/Objectives Tessellated fundus can exist in normal healthy eyes. This study aims to evaluate the occurrence and influencing factors of tessellated fundus in preschool children aged 3–6 years. Subjects/Methods This kindergarten-based cross-sectional study included 1716 children with an age range of 3–6 years. All participants underwent a comprehensive eye examination and a questionnaire. According
-
-
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspective Eye (IF 3.9) Pub Date : 2024-03-30 Aurelie Meunier, Oyin Opeifa, Louise Longworth, Oliver Cox, Christian Bührer, Isabelle Durand-Zaleski, Simon P. Kelly, Richard P. Gale
Background/Objectives Diabetic macular oedema (DMO) is a leading cause of blindness in developed countries, with significant disease burden associated with socio-economic deprivation. Distributional cost-effectiveness analysis (DCEA) allows evaluation of health equity impacts of interventions, estimation of how health outcomes and costs are distributed in the population, and assessments of potential
-
Central retinal artery occlusion: a stroke of the eye Eye (IF 3.9) Pub Date : 2024-03-28 Celia Chen, Gurfarmaan Singh, Reema Madike, Sudha Cugati
-
Herpes zoster in neuro-ophthalmology: a practical approach Eye (IF 3.9) Pub Date : 2024-03-27 Brendan Ka-Lok Tao, Deep Soor, Jonathan A Micieli
-
Ocular and orbital manifestations in VEXAS syndrome Eye (IF 3.9) Pub Date : 2024-03-28 Muhammad Abumanhal, Igal Leibovitch, Michael Zisapel, Tali Eviatar, Yonatan Edel, Ran Ben Cnaan
-
Refinements in the use of silicone oil as an intraocular tamponade Eye (IF 3.9) Pub Date : 2024-03-28 D. Ian Wilson, Andrew D. te Water Naude, Martin P. Snead
-
Exome sequencing and genome-wide association analyses unveils the genetic predisposition in hydroxychloroquine retinopathy Eye (IF 3.9) Pub Date : 2024-03-28 Hsun-I Chiu, Hui-Chen Cheng, Chih-Chiau Wu, Shih-Jen Chen, De-Kuang Hwang, Yi-Ming Huang, Yu-Bai Chou, Po-Kang Lin, Tai-Chi Lin, Ko-Hua Chen, Pei-Yu Lin, Yu-Fan Chang, An-Guor Wang
-
Three-year clinical outcome of XEN45 Gel Stent implantation versus trabeculectomy in patients with open angle glaucoma Eye (IF 3.9) Pub Date : 2024-03-28 Teresa Rauchegger, Sarah-Maria Krause, Yvonne Nowosielski, Anna Lena Huber, Peter Willeit, Eduard Schmid, Barbara Teuchner
-
Descemet’s membrane or confirmation of a novel corneal structure: the layer of Dua Eye (IF 3.9) Pub Date : 2024-03-27 Harminder S. Dua
Dear Editor, The brief communication by Athanasiadis et al. [1] highlights the issue of interpretation and clinico-histological correlation of images obtained by modern imaging techniques such as optical coherence tomography (OCT). This is reflected in the title of the communication, which questions whether the OCT image of a ‘double-contour-line’ in the posterior cornea represents the Descemet’s membrane
-
Programmed axon death: a promising target for treating retinal and optic nerve disorders Eye (IF 3.9) Pub Date : 2024-03-27 Andrea Loreto, Elisa Merlini, Michael P. Coleman
-
Associations between lipid abnormalities and diabetic retinopathy across a large United States national database Eye (IF 3.9) Pub Date : 2024-03-23 Hejin Jeong, Christopher M. Maatouk, Matthew W. Russell, Rishi P. Singh
Background/Objectives While dyslipidaemia has been suggested as a potential risk factor for diabetic retinopathy (DR), previous studies have reported conflicting findings. This study aimed to better characterize the relationship between abnormal serum levels of various lipid markers and the risk of the development and progression of DR. Subjects/Methods This retrospective cohort study utilized a United
-
Long-term observation of V4c implantable collamer lenses implantation for moderate to extreme high myopia correction: five years follow-up Eye (IF 3.9) Pub Date : 2024-03-22 Qi Wan, Peiyuan He, Ran Wei, Ke Ma, Hongbo Yin, Jing Tang, Ying-ping Deng
-
Diagnostic and therapeutic challenges in acute retinal necrosis; an update Eye (IF 3.9) Pub Date : 2024-03-22 Dimitrios Kalogeropoulos, Farid Afshar, Chris Kalogeropoulos, Georgios Vartholomatos, Andrew John Lotery
-
Retinal vasculature of different diameters and plexuses exhibit distinct vulnerability in varying severity of diabetic retinopathy Eye (IF 3.9) Pub Date : 2024-03-21 Alaa E. Fayed, Martin J. Menten, Linus Kreitner, Johannes C. Paetzold, Daniel Rueckert, Sherry M. Bassily, Ramy R. Fikry, Ahmed M. Hagag, Sobha Sivaprasad
-
Diagnosing glaucoma in primary eye care and the role of Artificial Intelligence applications for reducing the prevalence of undetected glaucoma in Australia Eye (IF 3.9) Pub Date : 2024-03-21 Catherine Jan, Mingguang He, Algis Vingrys, Zhuoting Zhu, Randall S. Stafford
-
ChatGPT-3.5 and Bing Chat in ophthalmology: an updated evaluation of performance, readability, and informative sources Eye (IF 3.9) Pub Date : 2024-03-20 Brendan Ka-Lok Tao, Nicholas Hua, John Milkovich, Jonathan Andrew Micieli
Background/Objectives Experimental investigation. Bing Chat (Microsoft) integration with ChatGPT-4 (OpenAI) integration has conferred the capability of accessing online data past 2021. We investigate its performance against ChatGPT-3.5 on a multiple-choice question ophthalmology exam. Subjects/Methods In August 2023, ChatGPT-3.5 and Bing Chat were evaluated against 913 questions derived from the Academy’s
-
Assessment of visual function using mobile Apps Eye (IF 3.9) Pub Date : 2024-03-20 Thaiba Bano, James S. Wolffsohn, Amy L. Sheppard
With the advances in smartphone and tablet screens, as well as their processing power and software, mobile apps have been developed reporting to assess visual function. This review assessed those mobile apps that have been evaluated in the scientific literature to measure visual acuity, reading metrics, contrast sensitivity, stereoacuity, colour vision and visual fields; these constitute just a small
-
Retinal sensitivity changes in early/intermediate AMD: a systematic review and meta-analysis of visual field testing under mesopic and scotopic lighting Eye (IF 3.9) Pub Date : 2024-03-18 Matt Trinh, Michael Kalloniatis, Sieu K. Khuu, Lisa Nivison-Smith
-
Comment on: ‘The impact of visual function on staircase use performance in glaucoma’ Eye (IF 3.9) Pub Date : 2024-03-15 Gordon N. Dutton
The article by Su et al. [1] has identified and rightly highlights that binocular lower visual field impairment poses a potential risk of injury when going down stairs. It concludes that those affected ‘should be warned about stair safety’. However, no information is provided concerning how the clinician can help diminish this risk. Those of us who are sighted have the facility to guide our movements
-
The potential key role of choroidal non-perfusion and rod degeneration in the pathogenesis of macular neovascularization type 3 Eye (IF 3.9) Pub Date : 2024-03-18 Bilal Haj Najeeb, Ursula Schmidt-Erfurth
-
Traumatic anterior lens dislocation with hyphaema entrapment between folds in the Descemet’s membrane Eye (IF 3.9) Pub Date : 2024-03-14 Vipul Ramjiani, Ayan Abdullahi
-
Comparison of the use of internal limiting membrane flaps versus conventional ILM peeling on post-operative anatomical and visual outcomes in large macular holes Eye (IF 3.9) Pub Date : 2024-03-16 George Riding, Boon Lin Teh, David Yorston, David H. Steel
Background Idiopathic full-thickness macular hole (iFTMH) closure rates following conventional vitrectomy, gas tamponade and internal limiting membrane (ILM) peeling decrease when the minimum linear diameter (MLD) ≥ 500 microns. ILM flap creation has been proposed to improve closure in larger holes. This study evaluated the anatomical and functional impact of ILM flap introduction to routine practice
-
Global Ophthalmology in the Middle East: a Task Force proposal Eye (IF 3.9) Pub Date : 2024-03-14 Mattan Arazi, Sila Bal, Joshua R. Ehrlich, Jacquelyn O’Banion, Fatma Shakarchi
The field of Global Ophthalmology is an evolving and rapidly expanding movement, as the global demand to address eyecare equity and preventable causes of vision impairment continues to grow [1, 2]. Globalization, while beneficial in many regards, has brought with it unique challenges to eyecare. Many of these challenges have been addressed through efforts such as capacity building, telemedicine, humanitarian
-
Visual outcomes and complications of combined versus sequential pars plana vitrectomy and phacoemulsification for epiretinal membrane Eye (IF 3.9) Pub Date : 2024-03-14 Yousef A. Fouad, Mohamed K. Soliman, Abdelrahman M. Elhusseiny, Yit C. Yang, Ahmed B. Sallam
-
Head to head comparison of diagnostic performance of three non-mydriatic cameras for diabetic retinopathy screening with artificial intelligence Eye (IF 3.9) Pub Date : 2024-03-11 Mehmet Erkan Doğan, Ahmet Burak Bilgin, Ramazan Sari, Mehmet Bulut, Yusuf Akar, Mustafa Aydemir
-
Variation in eye care professional distribution across Europe, a survey Eye (IF 3.9) Pub Date : 2024-03-12 Louis Arnould, Balazs Varsanyi, Edward Dervan, Chiara Posarelli, Helena Prior Filipe, Tristan Bourcier, Andreas Wedrich, Renata Ivekovic, Goran Petrovski, Giorgio L. Porro, Guna Laganovska, Vilma Jurate Balciuniene, Ewa Mrukwa-Kominek, Karsten Paust, Segolene Roemer, Ivan O. Haefliger, Huban Atilla, Paul Ursell, Barba Cvenkel, Jens Kiilgaard, Christina Grupcheva, Alena Furdova, Marnix Claeys, Klara
Eye care professionals across Europe encompass a range of professionals who screen, diagnose and treat ocular diseases. Their qualifications and roles might differ notably based on national regulations, healthcare system and number of ophthalmologists per inhabitants. There is little objective data presenting how the spectrum of eye care professionals differs between countries in Europe, and how their
-
Orbital CT scan parameters in dysthyroid optic neuropathy: a systematic review and meta-analysis Eye (IF 3.9) Pub Date : 2024-03-12 Thansit Srisombut, Niracha Arjkongharn, Nattaporn Vongsa, Arparat Kanacharoen, Parinee Kemchoknatee
-
Ultrawide-field fluorescein angiography features in patients with anterior uveitis Eye (IF 3.9) Pub Date : 2024-03-12 Nam V. Nguyen, Enny Oyeniran, Alexander Zeleny, Michelle Chen, Noha A. Sherif, Eleni Konstantinou, Susan Vitale, H. Nida Sen, Shilpa Kodati